Picture of Solid Biosciences logo

SLDB Solid Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Solid Biosciences Inc reports results for the quarter ended in September 30 - Earnings Summary

* Solid Biosciences Inc  SLDB.OQ  reported a quarterly
adjusted
loss of 79 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of $-1.05.  The mean expectation of nine analysts
for the quarter was for a loss of 67 cents per share. Wall
Street expected results to range from -70 cents to -63 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * Solid Biosciences Inc's reported EPS for the quarter was a
loss
of 79 cents​.
    * The company reported a quarterly loss of $32.73 million.
    * Solid Biosciences Inc shares had fallen by 14.8% this
quarter and lost 3.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Solid Biosciences
Inc is $16.00 
This summary was machine generated from LSEG data November 7 at
04:55 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.67          -0.79          Missed
 Jun. 30 2024      -0.66          -0.61          Beat
 Mar. 31 2024      -0.64          -0.64          Met
 Dec. 31 2023      -0.99          -1.00          Missed

Recent news on Solid Biosciences

See all news